loading page

Kimura’s disease treated with an anti-interleukin-5 antibody, mepolizumab: Relevance for its efficacy for the treatment of immunoglobulin G4-related diseases
  • +2
  • Manao Kinoshita,
  • Youichi Ogawa,
  • Misaki Onaka,
  • Shinji Shimada,
  • Tatsuyoshi Kawamura
Manao Kinoshita
University of Yamanashi

Corresponding Author:[email protected]

Author Profile
Youichi Ogawa
University of Yamanashi
Author Profile
Misaki Onaka
University of Yamanashi
Author Profile
Shinji Shimada
University of Yamanashi
Author Profile
Tatsuyoshi Kawamura
University of Yamanashi
Author Profile